Silence Therapeutics Plc ADR (XRP2)

Profile

https://www.silence-therapeutics.com

Silence Therapeutics Plc ADR is a biotechnology company focused on developing RNA-based medicines that use short interfering RNA, or siRNA, to regulate the activity of specific genes. Silence Therapeutics Plc ADR is working across hematology, cardiovascular disease, and rare diseases, with a pipeline that includes candidates designed to address blood disorders, complement-mediated renal conditions, and lipid-related cardiovascular conditions. The company’s research and development activities center on discovering and delivering novel RNA therapeutics that can silence disease-driving targets inside cells. Through its current product candidates and platform-driven approach, Silence Therapeutics Plc ADR plays a specialized role in the growing field of genetic medicine, where precision therapies are being developed for conditions with limited treatment options. The company is headquartered in London, United Kingdom.